However, it should be noted that for some of these diseases such as rheumatoid arthritis and multiple sclerosis there are conflicting reports demonstrating that inhibition of the MEK/ERK could ameliorate disease manifestation53,54 suggesting a more complex and different pathophysiology. This evidence concerns the gene MAP2K7 and multiple sclerosis.